SLI
2.065,54
PKT
-45,07
PKT
-2,14
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.10.05 | Holcim | Fuchsbriefe | |
| 27.10.05 | Nestlé | Zürcher Kantonalbank | |
| 28.10.05 | Nestlé buy | Bank Sarasin & Cie | |
| 26.10.05 | Novartis Hold | Deutsche Securities | |
| 26.10.05 | Nestlé kaufen | Banque SYZ & CO | |
| 25.10.05 | Nestlé in-line | Goldman Sachs | |
| 25.10.05 | Nestlé outperform | Credit Suisse First Boston | |
| 24.10.05 | Nestlé kaufen | Euro am Sonntag | |
| 21.10.05 | Nestlé akkumulieren | Independent Research | |
| 21.10.05 | UBS | DZ-Bank | |
| 21.10.05 | Novartis | DZ-Bank | |
| 21.10.05 | Novartis akkumulieren | Independent Research | |
| 21.10.05 | Nestlé overweight | JP Morgan | |
| 25.10.05 | Nestlé accumulate | Jyske Bank | |
| 20.10.05 | Novartis buy | Merrill Lynch | |
| 20.10.05 | Nestlé hold | SEB | |
| 20.10.05 | Holcim kaufen | Helaba Trust | |
| 20.10.05 | Nestlé reduce | SEB | |
| 19.10.05 | UBS buy | SEB | |
| 19.10.05 | Novartis outperform | Goldman Sachs | |
| 19.10.05 | Novartis overweight | Lehman Brothers | |
| 19.10.05 | Nestlé kaufen | Helaba Trust | |
| 20.10.05 | Novartis kaufen | Hamburger Sparkasse | |
| 19.10.05 | Novartis Outperform | Goldman Sachs | |
| 18.10.05 | Novartis neutral | Banc of America Sec. | |
| 19.10.05 | Novartis kaufen | Helaba Trust | |
| 21.10.05 | Novartis buy | Jyske Bank | |
| 18.10.05 | Novartis buy | Merrill Lynch | |
| 18.10.05 | Novartis buy | SEB | |
| 18.10.05 | Novartis Neutral | Banc of America Sec. | |
| 21.10.05 | Novartis halten | National-Bank AG | |
| 19.10.05 | Novartis market perform | Piper Jaffray | |
| 19.10.05 | Novartis overweight | Prudential Financial | |
| 17.10.05 | Novartis kaufen | Helaba Trust | |
| 17.10.05 | Nestlé overweight | JP Morgan | |
| 14.10.05 | ABB (Asea Brown Boveri) halten | Helaba Trust | |
| 14.10.05 | Swiss Life Marketperformer | LB Rheinland-Pfalz | |
| 18.10.05 | Novartis buy | Jyske Bank | |
| 14.10.05 | Swiss Life neutral | WestLB | |
| 13.10.05 | Swiss Life | Der Aktionär |